- Home
- MOGU vs COCP Comparison
MOGU vs COCP Comparison
Compare MOGU & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- COCP
- Stock Information
- Founded
- MOGU 2011
- COCP N/A
- Country
- MOGU China
- COCP United States
- Employees
- MOGU N/A
- COCP N/A
- Industry
- MOGU Business Services
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- COCP Health Care
- Exchange
- MOGU Nasdaq
- COCP Nasdaq
- Market Cap
- MOGU 21.0M
- COCP 20.1M
- IPO Year
- MOGU 2018
- COCP N/A
- Fundamental
- Price
- MOGU $2.54
- COCP $2.00
- Analyst Decision
- MOGU
- COCP Strong Buy
- Analyst Count
- MOGU 0
- COCP 1
- Target Price
- MOGU N/A
- COCP $7.00
- AVG Volume (30 Days)
- MOGU 11.3K
- COCP 87.4K
- Earning Date
- MOGU 11-22-2024
- COCP 11-13-2024
- Dividend Yield
- MOGU N/A
- COCP N/A
- EPS Growth
- MOGU N/A
- COCP N/A
- EPS
- MOGU N/A
- COCP N/A
- Revenue
- MOGU $19,801,126.00
- COCP N/A
- Revenue This Year
- MOGU N/A
- COCP N/A
- Revenue Next Year
- MOGU N/A
- COCP N/A
- P/E Ratio
- MOGU N/A
- COCP N/A
- Revenue Growth
- MOGU N/A
- COCP N/A
- 52 Week Low
- MOGU $1.62
- COCP $1.33
- 52 Week High
- MOGU $3.58
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- MOGU 60.34
- COCP 45.18
- Support Level
- MOGU $2.32
- COCP $1.88
- Resistance Level
- MOGU $2.69
- COCP $2.17
- Average True Range (ATR)
- MOGU 0.28
- COCP 0.28
- MACD
- MOGU 0.02
- COCP -0.06
- Stochastic Oscillator
- MOGU 71.95
- COCP 16.67
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).